Santiago, Chile

Julia Christin Berning

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Notco Delaware, LLC. Active years: 2021-2023.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Julia Christin Berning

Introduction

Julia Christin Berning is an accomplished inventor based in Santiago, Chile. She has made significant contributions to the field of artificial intelligence and protein structure prediction. With a total of 2 patents, her work is paving the way for advancements in biotechnology.

Latest Patents

One of her latest patents involves a novel artificial intelligence model designed to predict protein secondary structures. This model utilizes a Fourier-transform infrared (FTIR) spectrum of a given ingredient to generate predictions. It includes three artificial modules that produce predicted values corresponding to structural categories such as α-helix, β-sheet, and others. This innovation allows for the comparison of proteins based on their predicted structural similarities.

Career Highlights

Julia is currently employed at Notco Delaware, LLC, where she continues to develop her groundbreaking technologies. Her work is instrumental in enhancing the understanding of protein structures, which has implications for various applications in biotechnology and food science.

Collaborations

Julia collaborates with talented individuals such as Nathan O'Hara and Adil Yusuf, contributing to a dynamic and innovative work environment.

Conclusion

Julia Christin Berning is a remarkable inventor whose work in artificial intelligence and protein structure prediction is making a significant impact in her field. Her contributions are essential for future advancements in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…